Fig. 1: Nanoparticle morphology.
From: Catalytic activity imperative for nanoparticle dose enhancement in photon and proton therapy
Representative TEM images (overall more than 200 nanoparticles and at least five regions of the sample analyzed for each particle type) of commercially available SiO2 (a, A380, Evonik Industries AG, Germany), FSP synthesized metal oxide or nitride nanoparticles (b–e) and commercially available 50 nm Au nanoparticles (f).
